United States · FDA National Drug Code directory

Erigeron Canadensis

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
37662-0709_e301c983-7b0c-234e-e053-2995a90a3a0f
Product NDC
37662-0709
Form
PELLET
Composition / generic term
Erigeron Canadensis
Labeler
Hahnemann Laboratories, INC.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20220704
Source listing expiry
20261231

Source-listed ingredients

  • ERIGERON CANADENSIS — 1 [hp_M]/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 200 PELLET in 1 VIAL, GLASS (37662-0709-1) · 37662-0709-1
  • 500 PELLET in 1 VIAL, GLASS (37662-0709-2) · 37662-0709-2
  • 3000 PELLET in 1 BOTTLE, GLASS (37662-0709-3) · 37662-0709-3
  • 10000 PELLET in 1 BOTTLE, GLASS (37662-0709-4) · 37662-0709-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →